Skip to main content

Table 3 Change of FMD and SPP

From: Improvement of microcirculatory impairment in patients with predialysis chronic kidney disease after AST-120 administration

Months

-3

0

3

6

12

FMD (%)

4.49 ± 1.70

4.03 ± 2.80

4.06 ± 1.82

3.85 ± 1.85

3.46 ± 1.55

SPP (mmHg)

70.8 ± 10.2

69.7 ± 14.6

74.2 ± 9.7

75.0 ± 10.6

78.8 ± 18.9*

  1. FMD flow mediated dilation, ACS arterial calciication score, SPP skin perfusion pressure
  2. *p < 0.05 vs. 0 month
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us